...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Endocyte vs Zenith
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I agree that the CAR-T program has no relevance to Zenith.

I disagree somewhat about the increase in stock price. I know many investors who have a high opinion of ECYT due to the CAR-T program and their involvement with the Juno originator.

Anyway, I agree with your summary on the prostate end of things.

 

bfw

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply